Clinical Trial Update: A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for AXS-02 in knee osteoarthritis with bone marrow lesions; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• AXS-02

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: UNKNOWN